MapLight Therapeutics (MPLT) General Counsel Kristopher Hanson Sells Shares

What Happened

• Kristopher Hanson, General Counsel of MapLight Therapeutics (MPLT), sold a total of 16,508 shares in a series of open-market dispositions from July 15–17, 2026, generating approximately $607,870 in proceeds. The sales were reported as "S" (sales) on the Form 4 and occurred at prices ranging roughly from $35.53 to $37.96 per share.
• Daily breakdown: July 15 — 7,260 shares for ~$266,427 (multiple trades); July 16 — 8,118 shares for ~$298,616 (multiple trades); July 17 — 1,130 shares for ~$42,827. At least some of the shares sold were to cover statutory tax withholding on vested restricted stock units (non‑discretionary "sell-to-cover").

Key Details

• Transaction dates: July 15–17, 2026. Filing date: July 17, 2026. No late filing notation is indicated in the provided data.
• Total sold: 16,508 shares for total proceeds of about $607,870.
• Price details: filing footnotes show weighted-average sale-price ranges across the trades (examples include ~$35.53–$36.53, ~$36.53–$37.405, ~$35.91–$36.90, ~$36.91–$37.89, and ~$37.49–$37.925).
• Footnotes: F1 indicates some shares were sold to satisfy statutory tax withholding on RSU vesting (a mandated "sell-to-cover" and not a discretionary sale). Other footnotes (F2–F6) explain that reported prices are weighted averages across multiple transactions and the filer can provide detailed per-trade pricing on request.
• Shares owned after transaction: not specified in the information provided.

Context

• Sales to cover taxes on vested restricted stock units are common and are not generally interpreted as a personal decision to divest equity; they are administrative (tax) transactions.
• These were all sales (S). Sales are common among insiders for a variety of reasons and, absent other information, do not necessarily signal negative views about the company.